Company
Relevium Medical
- Biotech
- Location:
- Galway, Ireland
Description
Relevium Medical develops injectable hydrogel, TRPV1-targeting prodrug therapeutics designed to ablate or modulate peripheral nervous system hyperexcitability for long-lasting relief in chronic pain and urology disorders.
Related
VersonoVersono develops the ProSonic™ System, an intravascular ultrasonic platform that uses axial and radial ultrasonic energy to cross complex…
Neurent MedicalNeurent Medical develops the NEUROMARK System, a radiofrequency-based ENT medical device that targets posterior nasal nerves to provide…
Anacalypsis TherapeuticsAnacalypsis Therapeutics creates precision gene- and pathway-based therapeutic strategies, biomarkers, and genetically linked targets to…
LaNua MedicalLaNua Medical is developing ECORE™, an embolization device designed to block blood flow, address unwanted embolization reflux, and give…
EVerZomEVerZom develops exosome therapeutics by combining proprietary manufacturing and formulation technologies for scalable, reproducible, and…
MinzeMinze provides digital urology tools for male LUTS/BPH and overactive bladder, pairing clinic or home uroflowmetry with automated bladder…
BiograilBiograil develops proprietary BIONDD® technology for oral delivery of biologics, using it in preclinical pharmaceutical work to turn…
NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
PharmathenPharmathen develops and manufactures pharmaceutical dosage forms, APIs, and formulation technologies for branded and generic partners,…